Orange Book product · Generic (ANDA)
REMIFENTANIL HYDROCHLORIDE
REMIFENTANIL HYDROCHLORIDE
Generic (ANDA)ANDA 206223TE APRX FRESENIUS KABI USA
At a glance
Jan 16, 2018
Approved
Generic (ANDA)
Application
AP
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Jan 16, 2018
8 yr 7 mo ago
Today
Pharmaceutical detail
Active ingredient
REMIFENTANIL HYDROCHLORIDE
Strength
EQ 1MG BASE/VIAL
Dosage form
INJECTABLE
Route
INJECTION
TE code
AP
Application
ANDA 206223
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of REMIFENTANIL HYDROCHLORIDE
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
